Nuclear Medicine Clarification Act of 2025
Official title: To require the Nuclear Regulatory Commission to revise its regulations to protect patients from unintended exposure to radiation during nuclear medicine procedures, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Nuclear Medicine Clarification Act of 2025
This bill requires the Nuclear Regulatory Commission (NRC) to revise its regulations so that health care providers must report to the NRC when a dose of a radioactive drug caused by an extravasation exceeds specified quantities. An extravasation generally means the unintentional presence of a radioactive drug in the tissue surrounding the blood vessel following an injection.
Under the NRC’s current regulations, health care providers licensed by the NRC to use radioactive materials must submit a report to the NRC for any instance, known as a medical event, where the administered dose of a radioactive drug exceeds specified quantities or criteria.
In 2024, the NRC published a draft proposed rule that would add an extravasation as a medical event that must be reported. The draft proposed rule’s reporting threshold is based on a physician’s determination that the administration results or may potentially result in a radiation injury from an extravasation. The reporting threshold proposed by the NRC does not contain a quantified dose.
The bill requires the NRC to revise its regulations to add an extravasation as a medical event that must be reported, and it additionally requires the reporting threshold to be based on quantified doses (as specified in the bill).
- Introduced in House Formatted Text PDF Formatted XML
- CAPITOL ASSOCIATES, INC.
- CAPITOL ASSOCIATES, INC.
- SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- CAPITOL ASSOCIATES, INC.
- SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- ARNOLD & PORTER KAYE SCHOLER LLP
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Nuclear Regulatory Commission (NRC)
Cite this page
U.S. Congress. (2026). H.R. 2541: Nuclear Medicine Clarification Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-2541/
"H.R. 2541: Nuclear Medicine Clarification Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-2541/.
H.R. 2541, 119th Cong. (2026), https://openamerica.io/bill/119-HR-2541/.
[H.R. 2541: Nuclear Medicine Clarification Act of 2025](https://openamerica.io/bill/119-HR-2541/)